Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.
about
Current status and future directions of botulinum neurotoxins for targeting pain processingBotulinum Toxin for Neuropathic Pain: A Review of the LiteratureTreatment of Chronic Migraine with Focus on Botulinum NeurotoxinsBotulinum Toxin as a Pain Killer: Players and Actions in AntinociceptionBotulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-RehabilitationCentral action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy.The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytesCritical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats.Evidence-based knee injections for the management of arthritis.None detectable retrograde transport of Chinese botulinum toxin type A in mice by single intramuscular injection.Clinical uses of botulinum neurotoxins: current indications, limitations and future developmentsBotulinum toxin type A for neuropathic pain in patients with spinal cord injury.The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy.Treatment of refractory pain with botulinum toxins--an evidence-based review.Botulinum neurotoxin for pain management: insights from animal models.Diffusion, spread, and migration of botulinum toxin.More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behaviorBotulinum Toxin: Pharmacology and Therapeutic Roles in Pain States.Bilateral analgesic effects of abobotulinumtoxinA (Dysport® ) following unilateral administration in the rat.Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.Intra-articular injections of botulinum toxin a for refractory joint pain: a systematic review and meta-analysis.Botulinum toxin type A in motor nervous system: unexplained observations and new challenges.Abobotulinum Toxin A in the Treatment of Chronic Low Back PainBotulinum toxin type A as an adjunct in postoperative pain management in dogs undergoing radical mastectomy.Spinal Central Effects of Peripherally Applied Botulinum Neurotoxin A in Comparison between Its Subtypes A1 and A2.Botulinum Toxin for the Treatment of Neuropathic Pain.Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells.Botulinum toxin type A reduces hyperalgesia and TRPV1 expression in rats with neuropathic pain.Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain.Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis.Botulinum Toxin for Central Neuropathic Pain.
P2860
Q26778129-E688E226-5C03-4DDA-B585-5F4DAE7EF464Q26796604-35A6BC6B-B9A0-41AC-9B7B-249A8A50C261Q26799906-2EA48F46-188B-4AF4-88E8-DD1A7912ECF5Q28084583-5D3D1EA0-1169-49EC-BDB0-8F17D724B133Q28088625-5815F999-A5A5-411F-BF57-252D834283BBQ34125262-FAF3A6E6-A060-4C05-B1B4-7B87F54B3E6AQ34460791-C9B44458-5FB8-4D32-9C73-A8AF3C8C22B3Q35681903-AE90336C-E952-422B-962A-AC9452A2106BQ35691221-FFC2CD62-D5F5-4B73-A248-E4AE6BC6E7FBQ35843970-9852E2E4-6BBF-4B68-9B88-BA9F8DB8A754Q36035614-46C89942-B475-4694-AA4D-287D25D9B3ACQ36317697-79D7C713-5078-4D8E-B556-366BC7BAD004Q36395728-063CEC4B-1D6F-4DC2-8259-4E742796C16FQ36780108-BBA1253E-4049-4E04-9A10-DDB10FFD179EQ37723197-18EF6391-E5F9-4042-84E5-6172C440684CQ37940623-7B5FDF9C-E0A4-4624-AD97-5922BB45DCEBQ37954278-C96ACBE2-2D58-497C-9347-0F7E2744959DQ38122648-E345B656-E576-4BEA-B625-9F5FD17887A5Q38191755-E913C1B5-D666-4A55-8D76-8DF5F6BC52BDQ38365855-A59019EB-9B71-4074-B399-13E34337A667Q38734744-81553DDD-8580-4700-A8B0-02C951375FFDQ38750238-EF381A0C-B1C5-4430-A501-27FFB7EA6991Q38798588-0A1FE99D-5875-415A-B3B6-BDE6635D5194Q38812041-1CFF630F-8A80-45CB-9C28-541E6774E55DQ38944196-C09D7FD8-8B3A-47BA-8024-C0035E74DE61Q39095007-7DAAE375-1448-4945-9B07-E9E54E79AFFBQ40455025-752355A9-D48F-4C07-9C32-FF77B1BAE4D4Q40983059-88BF68BF-D7E6-479B-B262-3F543B3D7C25Q41669358-CE371E1E-418B-47CF-BB83-1DECF6029BD6Q42838523-D459367D-887E-4947-893D-B706308F09E2Q45731235-5B79611C-1294-4C40-971B-09D6A67E83F4Q48306948-F09236D0-F71B-4050-A98C-09B69BED20BDQ48579779-D21E1A3A-FF1F-4F80-B65E-28C3A4302D1BQ54357961-AEDE35EA-AA1F-4416-BECB-7B56F0E0C249Q55498097-6233216C-5022-418E-AFF0-E682CEED4596
P2860
Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Botulinum toxin type A reduces ...... ct after unilateral injection.
@en
Botulinum toxin type A reduces ...... ct after unilateral injection.
@nl
type
label
Botulinum toxin type A reduces ...... ct after unilateral injection.
@en
Botulinum toxin type A reduces ...... ct after unilateral injection.
@nl
prefLabel
Botulinum toxin type A reduces ...... ct after unilateral injection.
@en
Botulinum toxin type A reduces ...... ct after unilateral injection.
@nl
P2093
P1476
Botulinum toxin type A reduces ...... ct after unilateral injection.
@en
P2093
Lidija Bach-Rojecky
Melita Salković-Petrisić
Zdravko Lacković
P356
10.1016/J.EJPHAR.2010.01.020
P407
P577
2010-02-01T00:00:00Z